Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
Status:
Terminated
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
M40403 was found to be effective in reducing pain in animal models and in clinical studies of
subjects who were experiencing pain after dental surgery. The proposed study is designed to
investigate the efficacy and safety of M40403 when co-administered with an opioid in subjects
with pain due to cancer.